Company · Ownership research

Keysight Technologies, Inc. KEYS

CIK 0001601046

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 89 rows; the complete set is available through the API.

Insider filings on file run through Oct 20, 2026.

Insider purchases & sales

Purchased: $110.46K
Sold: $73.63M

Nov 1, 2023 – Oct 20, 2026
Available records · partial months are marked ·

202410 of 13 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 30, 2024	WALLACE Mark ADAM SVP	Sale	$970.77K 6,000 shares sold	6.53% sold Direct holding	▾
Dec 4, 2024	Li Jeffrey K SVP and Secretary	Sale10b5-1 footnote	$758.51K 4,412 shares sold	12.59% sold Direct holding	▾
Dec 3, 2024	Nersesian Ronald S. Director	Sale	$7.14M 41,911 shares sold	15.04% sold Direct holding	▾
Dec 3, 2024	Gooi Soon Chai SVP	Sale	$3.12M 18,212 shares sold	7.31% sold Direct holding	▾
Dec 2, 2024	Dhanasekaran Satish President and CEO · Director	Sale10b5-1 footnote	$3.02M 17,822 shares sold	13.26% sold Direct holding	▾
Dec 2, 2024	PAGE JOHN SVP	Sale10b5-1 footnote	$658.96K 3,884 shares sold	9.48% sold Direct holding	▾
Dec 2, 2024	Gooi Soon Chai SVP	Sale10b5-1 footnote	$1.48M 8,703 shares sold	3.38% sold Direct holding	▾
Nov 27, 2024	NARAYANAN KAILASH SVP	Sale10b5-1 footnote	$101.92K 595 shares sold	1.63% sold Direct holding	▾
Nov 25, 2024	POOLE LISA M. VP and Controller	Sale	$60.13K 350 shares sold	6.77% sold Direct holding	▾
Aug 22, 2024	HAMADA RICHARD P Director	Sale	$254.59K 1,632 shares sold	3.73% sold Direct holding	▾

Showing 13 / 13 record groups in 2024. The complete set is available through the API.

Keysight Technologies, Inc. · KEYS

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 13 of 13 purchase / sale groups and 30 of 89 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"KEYS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.